secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEMAITRE VASCULAR INC (LMAT)
CIK:        0001158895
Form:       8-K
Filed at:   2024-08-01T23:59:59+00:00
Accession:  0001437749-24-024304
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LeMaitre Q2 EPS $0.52 +44%, FY guidance raised; dividend $0.16
--------------------------------------------------------------

- Sales $55.8M +11% (+12% organic); EPS $0.52 +44% vs Q2 2023.
- Gross margin 68.9% (+490 bps); operating income $14.4M +52%.
- Allografts +30%, bovine patches +12%, carotid shunts +22% led growth.
- Q3 guidance: sales $52.7-54.7M, EPS $0.42-0.46; FY guidance raised to sales $218.8M, EPS $1.82-1.91.
- Quarterly dividend $0.16/share payable Aug 29, record Aug 15.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158895/000143774924024304/0001437749-24-024304-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158895/000143774924024304/lmat20240801_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-024304

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer